Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Sphingosine 1-phosphate antagonizes the effect of all-trans retinoic acid (ATRA) in a human colon cancer cell line by modulation of RARβ expression.
Sun DF, Gao ZH, Liu HP, Yuan Y, Qu XJ.
Cancer Lett. 2012 Jun 28;319(2):182-9. Epub 2012 Jan 17.
Related citations
TGF-beta signalling in colon carcinogenesis.
Lampropoulos P, Zizi-Sermpetzoglou A, Rizos S, Kostakis A, Nikiteas N, Papavassiliou AG.
Cancer Lett. 2012 Jan 1;314(1):1-7. Epub 2011 Oct 7. Review.
Epigenetic biomarkers of colorectal cancer: Focus on DNA methylation.
Coppedè F.
Cancer Lett. 2011 Dec 24. [Epub ahead of print]
Preparation of camptothecin-loaded PCEC microspheres for the treatment of colorectal peritoneal carcinomatosis and tumor growth in mice.
Dai M, Xu X, Song J, Fu S, Gou M, Luo F, Qian Z.
Cancer Lett. 2011 Dec 22;312(2):189-96. doi: 10.1016/j.canlet.2011.08.007. Epub 2011 Aug 31.
Platelet-derived endothelial cell growth factor/thymidine phosphorylase inhibitor augments radiotherapeutic efficacy in experimental colorectal cancer.
Miyatani T, Kurita N, Utsunomiya T, Iwata T, Nishioka M, Yoshikawa K, Higashijima J, Kashihara H, Takasu C, Fukushima M, Shimada M.
Cancer Lett. 2012 May 28;318(2):199-205. doi: 10.1016/j.canlet.2011.12.010. Epub 2011 Dec 13.
A phase II study of neoadjuvant chemoradiotherapy with oxaliplatin and capecitabine for rectal cancer.
Zhao L, Bai C, Shao Y, Guan M, Jia N, Xiao Y, Qiu H, Zhang F, Yang T, Zhong G, Chen S.
Cancer Lett. 2011 Nov 28;310(2):134-9. Epub 2011 Jul 5.
P-21 activated kinase 1 knockdown inhibits β-catenin signalling and blocks colorectal cancer growth.
He H, Huynh N, Liu KH, Malcontenti-Wilson C, Zhu J, Christophi C, Shulkes A, Baldwin GS.
Cancer Lett. 2012 Apr 1;317(1):65-71. Epub 2011 Nov 15.
miR-21 functionally interacts with the 3'UTR of chemokine CCL20 and down-regulates CCL20 expression in miR-21 transfected colorectal cancer cells.
Vicinus B, Rubie C, Faust SK, Frick VO, Ghadjar P, Wagner M, Graeber S, Schilling MK.
Cancer Lett. 2012 Mar;316(1):105-12. Epub 2011 Oct 29.
Gut microbiota and probiotics in colon tumorigenesis.
Zhu Y, Michelle Luo T, Jobin C, Young HA.
Cancer Lett. 2011 Oct 28;309(2):119-27. Epub 2011 Jun 24. Review.
Differential dependency of human cancer cells on vascular endothelial growth factor-mediated autocrine growth and survival.
Lee J, Lee J, Yu H, Choi K, Choi C.
Cancer Lett. 2011 Oct 28;309(2):145-50. Epub 2011 Jun 16.
NIH-3T3 fibroblasts cultured with plasma from colorectal cancer patients generate poorly differentiated carcinomas in mice.
Serrano-Heras G, Domínguez-Berzosa C, Collantes E, Guadalajara H, García-Olmo D, García-Olmo DC.
Cancer Lett. 2012 Mar;316(1):85-90. Epub 2011 Oct 25.
Selenite induces apoptosis in colorectal cancer cells via AKT-mediated inhibition of β-catenin survival axis.
Luo H, Yang Y, Huang F, Li F, Jiang Q, Shi K, Xu C.
Cancer Lett. 2012 Feb 1;315(1):78-85. doi: 10.1016/j.canlet.2011.10.014. Epub 2011 Oct 21.
Nanoliposome-mediated FL/TRAIL double-gene therapy for colon cancer: in vitro and in vivo evaluation.
Sun NF, Meng QY, Tian AL, Hu SY, Wang RH, Liu ZX, Xu L.
Cancer Lett. 2012 Feb 1;315(1):69-77. doi: 10.1016/j.canlet.2011.10.010. Epub 2011 Oct 18.
NIRF is frequently upregulated in colorectal cancer and its oncogenicity can be suppressed by let-7a microRNA.
Wang F, Zhang P, Ma Y, Yang J, Moyer MP, Shi C, Peng J, Qin H.
Cancer Lett. 2012 Jan 28;314(2):223-31. Epub 2011 Oct 5.
Lunasin potentiates the effect of oxaliplatin preventing outgrowth of colon cancer metastasis, binds to α5β1 integrin and suppresses FAK/ERK/NF-κB signaling.
Dia VP, Gonzalez de Mejia E.
Cancer Lett. 2011 Dec 27;313(2):167-80. Epub 2011 Sep 10.
Knockdown of RAGE expression inhibits colorectal cancer cell invasion and suppresses angiogenesis in vitro and in vivo.
Liang H, Zhong Y, Zhou S, Peng L.
Cancer Lett. 2011 Dec 26;313(1):91-8. Epub 2011 Sep 6.
Stromal cells do not share KRAS mutations that the epithelial component harbors in colorectal carcinomas.
Baloglu H, Yigit N.
Cancer Lett. 2011 Sep 1;308(1):118-21. Epub 2011 May 31.
RasGAP-derived peptide 38GAP potentiates the cytotoxicity of cisplatin through inhibitions of Akt, ERK and NF-κB in colon carcinoma HCT116 cells.
Zhang H, Zhang S, He H, Zhao W, Ren K, Chen J, Shao RG.
Cancer Lett. 2011 Sep 1;308(1):62-70. Epub 2011 May 13.
Reverse phase protein microarrays quantify and validate the bioenergetic signature as biomarker in colorectal cancer.
Aldea M, Clofent J, Núñez de Arenas C, Chamorro M, Velasco M, Berrendero JR, Navarro C, Cuezva JM.
Cancer Lett. 2011 Dec 8;311(2):210-8. Epub 2011 Aug 6.
Neo-angiogenesis and the premalignant micro-circulatory augmentation of early colon carcinogenesis.
Tiwari AK, Crawford SE, Radosevich A, Wali RK, Stypula Y, Kunte DP, Mutyal N, Ruderman S, Gomes A, Cornwell ML, De La Cruz M, Brasky J, Gibson TP, Backman V, Roy HK.
Cancer Lett. 2011 Jul 28;306(2):205-13. Epub 2011 Apr 14.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on